<DOC>
	<DOCNO>NCT02056665</DOCNO>
	<brief_summary>RANDOMIZED CLINICAL TRIAL , PLACEBO COMPARED TO EVALUATE THE EFFICACY AND SAFETY OF MINOCYCLINE IN ANGELMAN SYNDROME ( A-MANECE STUDY )</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Minocycline Angelman Syndrome</brief_title>
	<detailed_description>STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MINOCYCLINE IN ANGELMAN SYNDROME</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Angelman Syndrome</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Male female 6 30 year old . Clinical diagnosis Angelman Syndrome molecular confirmation diagnosis . The participant acceptable guardian give consent behalf participant . Patients hypersensitivity tetracycline . Patients impaired hepatic renal function mainly drug allergy history . Any condition opinion investigator consider clinically relevant administration minocycline contraindicate</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Angelman Syndrome</keyword>
	<keyword>EFFICACY</keyword>
	<keyword>SAFETY</keyword>
	<keyword>MINOCYCLINE</keyword>
	<keyword>Pediatrics population</keyword>
	<keyword>Rare disease</keyword>
</DOC>